Experienced in Cystic Hygroma

Ying J. Yu

71 Xinmin Street, 
Changchun, CN 
Experienced in Cystic Hygroma
71 Xinmin Street, 
Changchun, CN 
OverviewLocationsClinical Research

Overview

Ying Yu practices in Changchun, China. Ms. Yu is rated as an Experienced expert by MediFind in the treatment of Cystic Hygroma. Her top areas of expertise are Ovarian Cancer, Subdural Effusion, Cystic Hygroma, Liver Transplant, and Hysterectomy.

Her clinical research consists of co-authoring 91 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Cystic Hygroma.

Gender
Female

Locations

71 Xinmin Street, Changchun, 130021, China
Other Locations
Xinmin Street, Changchun, 130021, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
Enrollment Status: Completed
Publish Date: August 27, 2025
Intervention Type: Drug
Study Drugs: Mirvetuximab Soravtansine, Paclitaxel, Topotecan, Pegylated liposomal doxorubicin
Study Phase: Phase 3

91 Total Publications

Advance in therapies targeting tumor-associated macrophages in ovarian cancer.
Advance in therapies targeting tumor-associated macrophages in ovarian cancer.
Journal: Frontiers in immunology
Published: August 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Yu's expertise for a condition
ConditionClose
      View All 30 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile